Abstract
Topical photodynamic therapy is used for the prevention and treatment of non-melanoma skin cancer. Until recently, clinically approved indications have been restricted to superficial basal cell carcinoma and nodular, actinic keratoses and, since 2006, Bowen’s disease. Most photosensitizers are relatively hydrophobic and will be attracted to membranes, but even the exception molecules, having substituents that render them watersoluble, bind to membranes because of their hydrophobic ring systems. The primary function of the skin, however, is to protect the body from unwanted influences from the environment. This protection is provided primarily by the stratum corneum, which consists of corneocytes surrounded by lipid regions. The major limitation of PDT is the poor penetration of photosensitizers through biological barriers, like the skin. Over the past 10 years, a considerable number of studies have therefore been conducted on the development of different strategies to overcome these difficulties, including nanocarriers to delivery photosensitizers and their precursors, nanoemulsions, liposomes, ethosomes, invasomes, liquid crystals and magnetic nanoparticles, among others.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Chatterjee, D.K., Fong, L.S., Zhang, Y.: Nanoparticles in photodynamic therapy: An emerging paradigma. Adv. Drug Delivery Rev. 60, 1627–1637 (2008)
Medina, W.S., dos Santos, N.A., Curti, C., Tedesco, A.C., dos Santos, A.C.: Effects of zinc phthalocyanine tetrasulfonate-based photodynamic therapy on rat brain isolates mitochondria. Chem. Biol. Interact. 179, 402–406 (2009)
Hasan, T., Ortel, B., Moor, A.C.E., Pogue, B.W.: Photodynamic Therapy of Cancer. In: Kufe, D.W., Pollock, R.E., Weichselbaum, R.R., et al. (eds.) Holland-Frei Cancer Medicine, 6th edn., BC Decker, Hamilton Canadá (2003)
Gouterman, M.: Oxygen quenching of luminescence of pressure sensitive paint for wind tunnel research. J. Chem. Educ. 74, 697–702 (1997)
Smith, G., Mcgimpsey, W.G., Lynch, M.C., Kochevar, I.E., Redmond, R.W.: An efficient oxygen-independent two-photon photosensitization mechanism. Photochem. Photobiol. 59, 135–139 (1994)
Donnelly, R.F., Mccarron, P.A., Woolfson, D.: Drug Delivery Systems for Photodynamic Therapy. Recent. Pat. Drug Deliv. Formul. 3, 1–7 (2009)
Morgan, J., Oseroff, A.R.: Mitochondria-based photodynamic anti-cancer therapy. Adv. Drug. Deliv. Rev. 49, 71–86 (2001)
Turro, N.J., Yekta, A.: Luminescent probes for detergent solutions. A simple procedure for determination of the mean aggregation number of micelles. J. Am Chem. Soc. 100, 5951–5952 (1978)
Choudhary, S., Nouri, K., Elsaie, M.L.: Photodynamic therapy in dermatology: a review. Lasers Med. Sci. 24, 971–980 (2009)
Babilas, P., Landthaler, M., Szeimies, R.: Photodynamic therapy in dermatology. Eur. J. Dermatol. 16, 340–348 (2006)
Niwa, A.B.M., Neto, C.F.: Photodynamic therapy in dermatology: basic principles and clinical use. An Bras Dermatol. 84, 445–459 (2009)
Allison, R.R., Sibata, C.H., Downie, G.H., Cuenca, R.E.: A clinical review of PDT for cutaneous malignancies. Photodiagnosis Photodyn. Ther. 3, 214–226 (2006)
De Leeuw, J., Van Der Beek, N., Bjerring, P., Neumann, H.A.: Photodynamic therapy of acne vulgaris using 5-aminolevulinic acid 0.5% liposomal spray and intense pulsed light in combination with topical keratolytic agents. J. Eur. Acad. Dermatol. Venereol. 24, 460–469 (2010)
Fadel, M., Salah, M.L., Samy, N., Mona, S.: Liposomal methylene bleu hydrogel for selective photodynamic therapy of acne vulgaris. J. Drugs Dermatol. 8, 983–990 (2009)
Turchiello, R.F., Vena, F.C.B., Maillard, P., Souza, C.S., Bentley, M.V.B.L., Tedesco, A.C.: Cubic phase gel as a drug delivery system for topical application of 5-ALA, its ester derivatives and m-THPC in photodynamic therapy (PDT). J. Photochem. Photobiol., B 70, 1–6 (2003)
Steluti, R., De Rosa, F.S., Collett, J., Tedesco, A.C., Bentley, M.V.L.B.: Topical glycerol monooleate/propylene glycol formulations enhance 5-aminolevulinic acid in vitro skin delivery and in vivo protophorphyrin IX accumulation in hairless mouse skin. Eur. J. Pharm. Biopharm. 60, 439–444 (2005)
Bender, J.O., Ericson, M.B., Merclin, N., Iani, V., Rosén, A., Engstrom, S., Moan, J.: Lipid cubic phases for improved topical drug delivery in photodynamic therapy. J. Control Release 106, 350–360 (2005)
Garcia, F.S., Tedesco, A.C., Collett, J.H., Bentley, M.V.L.B.: Topical Delivery System for ZnPcSO4 based on liquid crystalline phases for use in PDT of skin cancer. In: 31st Annual Meeting and Exposition of Controlled Release Society, 2004, Honolulu-Hawai. Abstracts of 31st Annual Meeting and Exposition of Controlled Release Society, Honolulu, vol. 1, pp. 320–320 (2004)
Tsui-Min, T.: Mucoadhesive thermoresponsive medicament-carrier composition. United States Patent Application 20040009212 (2004)
Taylor, P.W., Love, W.G., Van Der Zanden, B.C.H.: Topically administrable zinc phthalocyanine compositions. US5616602 (1997)
Brow, S.B., O’Grady, C.C., Griffiths, J., Mellish, K.J., Vernon: D.I.: US20087371744 B2 (2008)
Allison, R.R., Downie, G.H., Cuenca, R., Hu, X.H., Childs, C.J.H., Sibata, C.H.: Photosensitizers in clinical PDT. Photodiagnosis Photodyn. Ther. 1, 27–42 (2004)
De Rosa, F.S.: Bentley MVLB Photodynamic Therapy of Skin Cancers: Sensitizers, Clinical Studies and Future Directives. Pharm. Res. 17, 1447–1455 (2000)
Robertson, C.A., Evans, D.H., Abrahamse, H.: Photodynamic therapy (PDT): A short review on cellular mechanisms and cancer research applications for PDT. J. Photochem Photobiol, B 96, 1–8 (2009)
Robertson, C.A., Evans, H.D., Abrahamse, H.: Photodynamic therapy (PDT): A short review on cellular mechanisms and cancer research applications for PDT. J. Photochem. Photobiol., B 17, 1–8 (2009)
Axcan Pharma, http://www.axcan.com (accessed September 20, 2010)
Visudyne Verteporfin for injection, http://www.visudyne.com (accessed September 25, 2010)
Winkelman, J.W., Collins, G.H.: Neurotoxicity of Tetraphenylporphinesulfonate Tpps4 and its relation to Photodynamic Therapy. Photochem. Photobiol. 46, 801–807 (1987)
Garcia, F.S., Nery, M.A., Tedesco, A.C., Bentley, M.V.L.B.: Phtalocyanine dyes: importance and future directives for use in photodynamic therapy of cancer. Trends in Photochemistry and Photobiology 10, 77–83 (2003)
Lieb, S., Szeimies, R.M., Lee, G.: Self adesive thin films for topical delivery of 5-aminolevulinic acid. Eur. J. Pharm. Biopharm. 53, 99–106 (2002)
Casas, A., Fukuda, G., Di Venosa, G., Del, A.M., Batlle, C.: The influence of the vehicle on the synthesis of porphyrins after topical application of 5- aminolevulinic acid implications in cutaneous photodynamic sensitisation. Br. J. Dermatol. 143, 564–572 (2000)
Malik, Z., Kostenich, G., Roitman, L., Ehrenberg, B., Orenstein, A.: Topical application of 5- aminolevulinic acid, DMSO and EDTA: protoporphyrin IX accumulation in skin and tumours of mice. J. Photochem. Photobiol., B 28, 213–218 (1995)
Morrow, D.I.J., Garland, M.J., Mccarron, P.A., Woolfson, A.D., Donnelly, R.F.: Innovative Drug Delivery Strategies for Topical Photodynamic Therapy using Porphyrin Precursors. J. Environ. Pathol. Toxicol. Oncol. 26, 105–116 (2007)
De Rosa, F.S., Collett, J., Tedesco, A.C., Bentley, M.V.L.B.: Topical glycerol monooleate/propylene glycol formulations enhance 5-aminolevulinic acid in vitro skin delivery and in vivo protophorphyrin IX accumulation in hairless mouse skin. Eur. J. Pharm. Biopharm. 60, 439–444 (2005)
De Rosa, F.S., Tedesco, A.C., Lopez, R.F.V., Pierre, M.B.R., Lange, N., Marchetti, J.M., Rotta, J.C.G., Bentley, M.V.L.B.: In vitro skin permeation and retention of 5-aminolevulinic acid ester derivatives for photodynamic therapy. J. Control Release 89, 261–269 (2003)
Casas, A., Batlle, A.M., Butler, A.R., Robertson, D., Brown, E.H., Macrobert, A., Riley, P.A.: Comparative effect of 5-ALA derivatives on protoporphyrin IX production in human and rat skin organ cultures. Br. J. Cancer 80, 1525–1532 (1999)
Lopez, R.F.V., Lange, N., Guy, R., Bentley, M.V.L.B.: Photodynamic therapy of skin cancer: controlled drug delivery of 5-ALA and its esters. Adv. Drug Deliv. Rev. 56, 77–94 (2004)
Dusa Pharmaceuticals, http://www.dusapharma.com/levulan-product-information.html (accessed September 22, 2010)
Metvix Galderma, S.A., http://www.metvix.com/home/about-metvix/overview (acessed September 25, 2010)
Spikes, J.D.: New trends in photobiology: Chlorins as photosensitizers in biology and medicine. J. Photochem. Photobiol., B 6, 259–274 (1990)
Biolitec Pharma, http://www.biolitecpharma.com/public/foscan.asp?s=foscan (acessed September 20, 2010)
Kalka, K., Merk, H., Mukhtar, H.: Photodynamic therapy in dermatology. J. Am. Acad. Dermatol. 42, 389–413 (2000)
Dube, A., Sharma, S., Gupta, P.K.: Evaluation of chlorin p6 for photodynamic treatment of squamous cell carcinoma in the hamster cheek pouch model. Oral Oncol. 42, 77–82 (2006)
Sheleg, S., Zhavrid, E.A., Khodina, T.V., Kochubeev, G.A., Istomin, Y.P., Chalov, V.N., Zhuravkin, I.N.: Photodynamic therapy with chlorin e6 for skin metastases of melanoma. Photodermatol. Photoimmunol. Photomed. 20, 21–26 (2004)
Garcia, F.S., Nery, M.A., Tedesco, A.C., Bentley, M.V.L.B.: Phtalocyanine dyes: importance and future directives for use in photodynamic therapy of cancer. Trends in Photochem. Photobiol. 10, 77–83 (2003)
Kyriazi, M., Alexandratou, E., Yova, D., Rallis, M., Trebst, T.: Opical photodynamic therapy of murine non-melanoma skin carcinomas with aluminum phthalocyanine chloride and a diode laser: pharmacokinetics, tumor response and cosmetic outcomes. Photodermatol. Photoimmunol. Photomed. 24, 87–94 (2008)
Gao, L., Qian, X., Zhang, L., Zhang, Y.: Tetra-trifluoroethoxyl zinc phthalocyanine: potential photosensitizer for use in the photodynamic therapy of cancer. J. Photochem. Photobiol., B 65, 35–38 (2001)
Kassab, K., Fabris, C., Defilippis, M.P., Dei, D., Fantetti, L., Roncucci, G., Reddi, E., Jori, G.: Skin-photosensitizing properties of Zn(II)-2(3), 9(10), 16(17), 23(24)-tetrakis-(4-oxy-N-methylpiperidinyl) phthalocyanine topically administered to mice. J. Photochem. Photobiol., B 55, 128–137 (2000)
Fabris, C., Soncin, M., Miotto, G., Fantetti, L., Chiti, G., Dei, D., Roncucci, G., Jori, G.: Zn(II)-phthalocyanines as phototherapeutic agents for cutaneous diseases. Photosensitization of fibroblasts and keratinocytes. J. Photochem. Photobiol. B 83, 48–54 (2006)
Sessler, J.L., Miller, R.A.: New drugs with diverse clinical applications in radiation and photodynamic therapy. Biochem. Pharmacol. 59, 733–739 (2000)
Boiy, A., De Witte, P.A.M., Roelandts, R.: Topical treatment of disseminated superficial actinic porokeratosis with hypericin—photodynamic therapy: A case report. Photodiagnosis Photodyn. Ther. 7, 123–125 (2010)
Tardivo, J.P., Del Giglio, A., De Oliveira, C.S., Gabrielli, D.S., Junqueira, H.C., Tada, D.B., Severino, D., Turchiello, R.F., Baptista, M.S.: Methylene blue in photodynamic therapy: From basic mechanisms to clinical applications. Photodiagnosis Photodyn. Ther. 2, 175–191 (2005)
Das, K., Jain, B., Patel, H.S.: Nile Blue in Triton-X 100/benzene–hexane reverse micelles: a fluorescence spectroscopic study. Spectrochimica Acta Part A 60, 2059–2064 (2004)
Hopper, C.: Photodynamic therapy: a clinical reality in the treatment of cancer. Lancet. Oncol. 1, 212–219 (2000)
Szeimies, R.M., Calzavara-Pinton, P.G., Karrer, S., Ortel, B., Landthaler, M.: Topical photodynamic therapy in dermatology. J. Photochem. Photobiol., B 36, 213–219 (1996)
De Rosa, F.S., Bentley, M.V.L.B.: Photodynamic Therapy of Skin Cancers: Sensitizers, Clinical Studies and Future Directives. Pharm. Res. 17, 1447–1455 (2000)
Turchiello, R.F., Vena, F.C.B., Maillard, P.H., Souza, C.S., Bentley, M.V.B.L., Tedesco, A.C.: Cubic phase gel as a drug delivery system for topical application of 5-ALA, its ester derivatives and m-THPC in photodynamic therapy (PDT). J. Photochem. Photobiol., B 70, 1–6 (2003)
Wester, R.C., Maibach, H.I.: Understanding percutaneous absorption for occupational health and safety. Int. J. Occup. Environ. Health 6, 86–92 (2000)
Wertz, P.W., Van Den Bergh, B.: The physical, chemical and functional properties of lipids in the skin and other biological barriers. Chem. Phys. Lipids 91, 85–96 (1998)
Bo, F., Engstramb, S., Engblomb, J., Norlkn, L.: A novel approach to the understanding of human skin barrier Function. J. Dermatol. Sci. 14, 115–125 (1997)
Bouwstra, J.A., Gooris, G.S., Dubbelaar, F.E.R., Ponec, M.: Phase behavior of lipid mixtures based on human ceramides: coexistence of crystalline and liquid phases. J. Lipid. Res. 42, 1759–1770 (2001)
Bouwstra, J.A., Dubbelaar, F.E.R., Gooris, G.S., Ponec, M.: The lipid organization in the skin barrier. Acta Derm. Venereol. 208, 23–30 (2000)
Bouwstra, J.A., Gooris, G.S., Cheng, K., Weerheim, A., Bras, W., Ponec, M.: Phase behaviour of isolated skin lipids. J. Lipid. Res. 37, 999–1011 (1996)
Naik, A., Kalia, Y.N., Guy, R.H.: Transdermal drug delivery: overcoming the skin’s barrier function. PSTT 3, 9 (2000)
Kalka, K., Merk, H., Mukhtar, H.: Photodynamic therapy in dermatology. J. Acad. Dermatol. 42, 389–413 (2000)
Darlenski, R., Sassning, S., Tsankov, N., Fluhr, J.W.: Non-invasive in vivo methods for investigation of the skin barrier physical properties. Eur. J. Pharm. Biopharm. 72, 295–303 (2009)
Bouwstra, J.A., Ponec, M.: The skin barrier in healthy and diseased state. Biochim. Biophys. Acta 1758, 2080–2095 (2006)
Fartash, M.: Epidermal barrier in disorders of the skin. Microsc. Res. Tech. 38, 361–372 (1997)
Hutcheson, A.C.S.H., Fisher, A.H., Lang, P.G.J.R.: Basal cell carcinomas with unusual histologic patterns. J. Am Acad. Dermatol. 53, 833–837 (2005)
Bouwstra, J.A.: The skin barrier, a well-organized membrane. Colloids Surf A Physicochem. Eng. Asp. 124, 403–413 (1997)
Ibbotson, S.H.: An overview of topical photodynamic therapy in Dermatology. Photodiagnosis Photodyn. Ther. 7, 16–23 (2010)
Cairnduff, F., Stringer, M.R., Hudson, E.J., Ash, D.V., Brown, S.B.: Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer. Br. J. Cancer 69, 605–608 (1994)
Sun, Y., Chen, Z., Yang, X., Huang, P., Zhou, X., Du, X.: Magnetic chitosan nanoparticles as a drug delivery system for targeting photodynamic therapy. Nanotechnology 20 135102, 8 (2009)
Jenning, V., Gysler, A., Schaèfer-Korting, M., Gohla, S.H.: Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. Eur. J. Pharm. Biopharm. 49, 211–218 (2000)
Alvarez-Román, R., Barré, G., Guy, R.H., Fessi, H.: Biodegradable polymer nanocapsules containing a sunscreen agent: preparation and photoprotection. Eur. J. Pharm. Biopharm. 52, 191–195 (2001)
Dahms, G.: 22nd International Federation of Societies of Cosmetic Chemists Congress. Edinburgh Oral Proceedings Keynote Lecture, pp. 519-529 (2002)
Pierre, M.B.R., Marchetti, J.M., Tedesco, A.C., Bentley, M.V.L.B.: Potential incorporation of 5- aminolevulinic acid in micelles and stratum corneum lipids liposomes: fluorescence quenching studies. Rev. Bras. Cienc. Farm. 37, 355–361 (2001)
Bender, J., Ericson, M.B., Merclin, N., Iani, V., Rosén, A., Engstrom, S., Moan, J.: Lipid cubic phases for improved topical drug delivery in photodynamic therapy. J. Control Release 106, 350–360 (2005)
Primo, F.L., Rodrigues, M.M.A., Simioni, A.R., Bentley, M.V.L.B., Morais, P.C., Tedesco, A.C.: In vitro studies of cutaneous retention of magnetic nanoemulsion loaded with zinc phthalocyanine for synergic use in skin cancer treatment. J. Magn. Magn. Mater. 320, 211–214 (2008)
Klesing, J., Wiehe, A., Gitter, B., Gräfe, S., Epple, M.: Positively charged calcium phosphate/polymer nanoparticles for photodynamic therapy. J. Mater. Sci. Mater. Med. 21, 887–892 (2010), doi:10.1007/s10856-009-3934-7
Vargas, A., Lange, N., Arvinte, T., Cerny, R., Gurny, R., Delie, F.: Toward the understanding of the photodynamic activity of m-THPP encapsulated in PLGA nanoparticles: correlation between nanoparticle properties and in vivo activity. J. Drug Target 17, 599–609 (2009)
Lee, S.J., Park, K., Oh, Y., Kwon, S., Her, S., Kim, I., Choi, K., Lee, S.J., Kim, H., Lee, S.G.: Kwon KKIC Tumor specificity and therapeutic efficacy of photosensitizer-encapsulated glycol chitosan-based nanoparticles in tumor-bearing mice. Biomaterials 30, 2929–2939 (2009)
Brasseur, N., Brault, D., Couvreur, P.: Adsorption of hematoporphyrin onto polyalkylcyanoacrylate nanoparticles: carrier capacity and drug release. Int. J. Pharm. 70, 129–135 (1991)
Labib, A., Lenaerts, V., Chouinard, F., Leroux, J.C., Ouellet, R., Van Lier, J.E.: Biodegradable Nanospheres Containing Phthalocyanines and Naphthalocyanines for Targeted Photodynamic Tumor Therapy. Pharm. Res. 8, 1027–1031 (1991)
Konan-Kouakou, Y.N., Boch, R., Gurny, R., Allemann, E.: In vitro and in vivo activities of verteporfin-loaded nanoparticles. J. Control Release 103, 83–91 (2005)
Konan, Y.N., Gurny, R., Allemann, E.: State of the art in the delivery of photosensitizers for photodynamic therapy. J. Photochem. Photobiol., B 66, 89–106 (2002)
Chatterjee, D.K., Fong, L.S., Zhang, Y.: Nanoparticles in photodynamic therapy: An emerging paradigm. Adv. Drug Deliv. Rev. 60, 1627–1637 (2008)
Ghosh, P.K., Murthy, R.S.R.: Microemulsions: a potential drug delivery system. Curr. Drug Deliv. 3, 167–180 (2006)
Guglielmini, G.: Nanostructured novel carrier for topical application. Clin. Dermatol. 26, 341–346 (2008)
Shafiq-Un-Nabi, S., Shakeel, F., Talegaonkar, S., Ali, J., Baboota, S., Ahuja, A., Khar, R.K., Ali, M.: Formulation Development and Optimization Using Nanoemulsion Technique: A Technical Note. AAPS Pharm. Sci. Tech. 8(2), Article 28 (2007)
Dahms, G.: 22nd International Federation of Societies of Cosmetic Chemists Congress. Edinburgh Oral Proceedings Keynote Lecture, pp. 519–529 (2002)
Tadros, T.: Presented at: 21st International Federation of Societies of Cosmetic Chemists Congress. Berlin Oral Proceedings, pp. 442–458 (2000)
Primo, F.L., Michieleto, L., Rodrigues, M.A.M., Macaroff, P.P., Morais, P.C., Lacava, Z.G.M., Bentley, M.V.L.B., Tedesco, A.C.: Magnetic nanoemulsions as drug delivery system for Foscans: Skin permeation and retention in vitro assays for topical application in photodynamic therapy (PDT) of skin cancer. J. Magn. Magn. Mater. 311, 354–357 (2007)
Gulati, M., Grover, M., Singh, S., Singh, M.: Lipophilic drug derivatives in liposomes. Int. J. Pharm. 165, 129–168 (1998)
Derycke, A.S.L., De Witte, P.A.M.: Liposomes for photodynamic therapy. Adv. Drug Deliv. Rev. 56, 17–30 (2004)
Pierre, M.B.R., Tedesco, A.C., Marchetti, J.M., Bentley, M.V.L.B.: Stratum corneum lipids liposomes for the topical delivery of 5-aminolevulinic acid in photodynamic therapy of skin cancer: preparation and in vitro permeation study. BMC Dermatol. 1, 5 (2001), doi:10.1186/1471-5945-1-5.
Han, I., Jun, M.S., Kim, S.K., Kim, M., Kim, J.C.: Expression pattern and intensity of protoporphyrin IX induced by liposomal 5-aminolevulinic acid in rat pilosebaceous unit throughout hair cycle. Arch. Dermatol. Res. 297, 210–217 (2005)
Di Venosa, G., Hermida, L., Batlle, A., Fukuda, H., Defain, M.V., Mamone, L., Rodriguez, L., Macrobert, A., Casas, A.: Characterization of liposomes containing aminolevulinic acid and derived esters. J. Photochem. Photobiol. B 92, 1–9 (2008)
Tapajós, E.C.C., Longo, J.P., Simioni, A.R., Lacava, Z.G.M., Santos, M.F.M.A., Morais, P.C., Azedesco, A.C., Azevedo, R.B.: In vitro photodynamic therapy on human oral keratinocytes using chloroaluminum-phthalocyanine. Oral Oncol. 44, 1073–1079 (2008)
Dragicevic-Curic, N., Scheglmann, D., Albrecht, V., Fahr, A.: Characterization, stability and in vitro skin penetration studies. Colloids and Surfaces B Biointerfaces 74, 114–122 (2009)
Fadel, M., Salah, M., Samy, N., Mona, S.: Liposomal methylene blue hydrogel for selective photodynamic therapy of acne vulgaris. J. Drugs Dermatol. 8, 983–990 (2009)
Rajashree, H., Harshal, G., Suneeta, S., Sujata, L., Vilasrao, K.: Ethosomes and its Applications in Transdermal Drug Delivery. Curr. Drug Ther. 4, 92–100 (2009)
Fang, Y., Tsai, Y., Wu, P., Huang, Y.: Comparison of 5-aminolevulinic acid-encapsulated liposome versus ethosome for skin delivery for photodynamic therapy. Int. J. Pharm. 356, 144–152 (2008)
Fang, Y.P., Huang, Y.B., Wu, P.C., Tsai, Y.H.: Topical delivery of 5-aminolevulinic acid-encapsulated ethosomes in a hyperproliferative skin animal model using the CLSM technique to evaluate the penetration behavior. Eur. J. Pharm. Biopharm. 73, 391–398 (2009)
Song, Y., Kim, C.: Topical delivery of low-molecular-weight heparin with surface-charged flexible liposomes. Biomaterials 27, 271–280 (2006)
Dragicevic-Curic, N., Gräfe, S., Gitter, B., Winter, S., Fahr, A.: Surface charged temoporfin-loaded flexible vesicles: In vitro skin penetration studies and stability. Int. J. Pharm. 384, 100–108 (2010)
Dragicevic-Curic, N., Scheglmann, D., Albrecht, V., Fahr, A.: Temoporfin-loaded invasomes: development, characterization and in vitro skin penetration studies. J. Control Release 127, 59–69 (2008)
Dragicevic-Curic, N., Gräfe, S., Albrecht, V., Fahr, A.: Topical application of temoporfin-loaded invasomes for photodynamic therapy of subcutaneously implanted tumours in mice: A pilot study. J. Photochem. Photobiol. B 91, 41–50 (2008)
Dragicevic-Curic, N., Scheglmann, D., Albrecht, V., Fahr, A.: Development of different temoporfin-loaded invasomes-novel nanocarriers of temoporfin: characterization, stability and in vitro skin penetration studies. Colloids Surf B Biointerfaces 70, 198–206 (2009)
Singh, S.: Phase transitions in liquid crystals. Phys. Rep. 324, 107–269 (2000)
Tyle, P.: Liquid Crystals and their applications in drug delivery. In: Rosoff, M. (ed.) Controlled Release of Drugs: Polymer and Aggregate Systems, ch. 4, pp. 125–162. VCH Publishers, New York (1989)
Alfons, K., Sven, E.M.: Drug Compatibility with the Sponge Phases Formed in Monoolein, Water, and Propylene Glycol or Poly(ethylene glycol). J. Pharm. Sci. 87, 1527–1530 (1998)
Carr, M.G., Corish, J., Corrigan, O.I.: Drug delivery from a liquid crystalline base across Visking and human stratum corneum. Int. J. Pharm. 157, 35–42 (1997)
Ganem-Quintanar, A., Quintanar-Guerrero, D., Buri, P.: Monoolein: a review of the pharmaceutical applications. Drug Dev. Ind. Pharm. 26, 809–820 (2000)
Caboi, F., Amico, G.S., Pitzalis, P., Monduzzi, M., Nylander, T., Larsson, K.: Addition of hydrophilic and lipophilic compounds of biological relevance to the monoolein:water system. I. Phase behavior. Chem. Phys. Lipids 109, 47–62 (2001)
Clogston, J., Rathman, J., Tomasko, D., Walker, H., Caffrey, M.: Phase behavior of a monoacylglycerol (Myverol 18-99K):water system. Chem. Phys. Lipids 107, 191–220 (2000)
Chang, C.M., Bodmeier, R.: Low viscosity monoglyceride-based drug delivery systems transforming into a highly viscous cubic phase. Int. J. Pharm. 173, 51–60 (1998)
Shah, J.C., Sadhale, Y., Chilukuri, M.D.: Cubic phase gels as drug delivery systems. Adv. Drug. Del. Rev. 47, 229–250 (2001)
Bender, J., Ericson, M.B., Merclin, N., Iani, V., Rosen, A., Engstrom, M.J.: Lipid cubic phases for improved topical drug delivery in photodynamic therapy. J. Control Release 106, 350–360 (2005)
Lopes, L.B., Ferreira, D.A., Paula, D., Garcia, M.T.J., Thomazini, J.A., Fantini, M.C., Bentley, M.V.L.B.: Reverse hexagonal phase nanodispersion of monoolein and oleic acid for topical delivery of peptides: in vitro and in vivo skin permeation of cyclosporin A. Pharm. Res. 23, 1332–1342 (2006)
Babincova, M., Babinec, P.: Magnetic Drug Delivery And Targeting:Principles And Applications. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 153, 243–250 (2009)
Morrish, A.H.: Physical Principles of Magnetism. IEEE Press, New York (2001)
Jain, T.K., Morales, M.A., Sahoo, S.K., Leslie-Pelecky, D.L., Labhasetwar, V.: Ion-oxide nanoparticles for sustained delivery of anticancer agents. Mol. Pharmacol. 2, 194–205 (2005)
Chertok, B., Moffat, B.A., David, A.E., Yu, F., Bergemann, C., Ross, B.D.: Iron oxide nanoparticles as a drug delivery vehicle for MRI monitores magnetic targeting of brain tumors. Biomaterials 29, 487–496 (2008)
Lu, Z.R., Ye, F., Vaidya, A.: Polymer Platforms for Drug Delivery and Biomedical Imaging. J. Control Release 122, 269–277 (2007)
Schwertmann, U., Cornell, R.M.: Iron oxides in the laboratory: preparation and characterization. VCH, Weinheim (1991)
Gupta, A.K., Gupta, M.: Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26, 3995–4021 (2005)
Berry, C.C., Curtis, A.S.G.: Functionalisation of magnetic nanoparticles for applications in biomedicine. J. Phys. D Appl. Phys. 36, R198–R206 (2003)
Sajja, H.K., East, M.P., Mao, H., Wang, Y.A., Nie, S., Yang, L.: Development of multifunctional nanoparticles for targeted drug delivery and noninvasive imaging of therapeutic effect. Curr. Drug Discov. Technol. 6, 43–51 (2009)
Kikumori, T., Kobayashi, T., Sawaki, M., Imai, T.: Anti-cancer effect of hyperthermia on breast cancer by magnetite nanoparticleloaded anti-HER2 immunoliposomes. Breast. Cancer. Res. Treat. 113, 435–441 (2009)
Babincova, M., Babinec, P.: Possibility of magnetic targeting of drugs using magnetoliposomes. Pharmazie 50, 828–829 (1995)
Yamashita, J., Shiono, M., Hato, M.: New lipid family that forms inverted cubic phases in equilibrium with excess water: molecular structure-aqueous phase structure relationship for lipids with 5,9,13,17-tetramethyloctadecyl and 5,9,13,17-tetramethyloctadecanoyl chains. J. Phys. Chem. B 112, 12286–12296 (2008)
Lee, E.S., Oh, Y.T., Youn, Y.S., Nam, M., Park, B., Yun, J., Kim, J.H., Song, H.T., Oh, K.T.: Binary mixing of micelles using Pluronics for a nanosized drug delivery system. Colloids Surf B Biointerfaces (2011), doi:10.1016/j.colsurfb.2010.08.033
Ferreira, D.A., Bentley, M.V.L.B., Karlsson, G., Edwards, K.: Cryo-TEM investigation of phase behaviour and aggregate structure in dilute dispersions of monoolein and oleic. Int. J. Pharm. 310, 203–212 (2006)
Lopes, L.B., Spereta, F.F.F., Bentley, M.V.L.B.: Enhancement of skin penetration of vitamin K using monoolein-based liquid crystalline systems. Eur. J. Pharm. Sci. 32, 209–215 (2007)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Medina, W.S.G., Praça, F.S.G., Carollo, A.R.H., Bentley, M.V.L.B. (2011). Nanocarriers to Deliver Photosensitizers in Topical Photodynamic Therapy and Photodiagnostics. In: Beck, R., Guterres, S., Pohlmann, A. (eds) Nanocosmetics and Nanomedicines. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-19792-5_15
Download citation
DOI: https://doi.org/10.1007/978-3-642-19792-5_15
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-19791-8
Online ISBN: 978-3-642-19792-5
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)